Equillium News and Activities

Equillium is a company listed under the stock ticker EQ (US).

View the org chart displaying its 11 main executives

Most searched biographies at Equillium

• Bruce Steel, Chief Executive Officer
• Daniel Bradbury, Chairman of the Board
• Charles McDermott, Director

Popular executive movements at Equillium

• Snehal Naik has joined the company as Chief Development Officer  (posted on May 14 2026).
• Bala Manian, Director, has left the company  (posted on October 7 2025).
• Stephen Connelly, who was Chief Scientific Officer and Director, is promoted to Chief Scientific Officer and President  (posted on October 7 2025).

Click here to view some more movements at Equillium

Create your alert
to follow the executive moves at Equillium.

Equillium has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).
• Rallybio and Avenzo Therapeutics have announced they will merge  (posted on June 1 2026)..

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Equillium

• Equillium Announces Poster Presentation at the Society for Immunotherapy of Cancer
• Equillium to Present at the Stifel Healthcare Conference
• Equillium Reports Third Quarter 2024 Financial Results and Provides Corporate and Clinical Updates
• Equillium Maintains Rights to Itolizumab Following Ono Partnership
• Equillium Announces Abstract Accepted for Poster Presentation at the Society for Immunotherapy of Cancer
• Equillium to Present at the Stifel Virtual Inflammation & Immunology Summit
• Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
• Equillium to Present at the Wells Fargo Healthcare Conference and the H.C. Wainwright 26th Annual Global Investor Conference
• Equillium Announces Second Quarter 2024 Estimated Cash and Investments Balance
• Equillium Reports Second Quarter 2024 Financial Results and Provides Recent Corporate and Clinical Highlights
• View more press releases Close

Social media about Equillium

• Equillium on Wikipedia, Google News & Yahoo Finance
• Equillium on LinkedIn, X (Twitter) & YouTube